Journal of Histochemistry and Cytochemistry, Vol. 51, 1027-1040, August 2003, Copyright © 2003, The Histochemical Society, Inc.
Expression of the Two Isoforms of the Vesicular Monoamine Transporter (VMAT1 and VMAT2) in the Endocrine Pancreas and Pancreatic Endocrine Tumors
Martin Anlaufa,d,
Rolf Eisseleb,
Martin K.-H. Schäfera,
Lee E. Eidenc,
Rudolf Arnoldb,
Ursula Pauserd,
Günter Klöppeld, and
Eberhard Weihea
a Department of Molecular Neuroscience, Institute of Anatomy and Cell Biology, Philipps University of Marburg
b Department of Gastroenterology and Endocrinology, Philipps University of Marburg, Marburg, Germany
c Section on Molecular Neuroscience, Laboratory of Cellular and Molecular Regulation, National Institute of Mental Health, NIMH, Bethesda, Maryland
d Department of Pathology, University of Kiel, Kiel, Germany
Correspondence to:
Eberhard Weihe, Dept. of Molecular Neuroscience, Inst. of Anatomy and Cell Biology, Philipps University, Robert-Koch Str. 6, 35037 Marburg, Germany. E-mail: weihe@staff.uni-marburg.de
The uptake of monoamines into the secretory granules of monoamine-storing neuroendocrine cells is mediated by vesicular monoamine transporter protein 1 or 2 (VMAT1 or VMAT2). This study analyzed the expression of VMAT1 and VMAT2 in endocrine cells of normal human and monkey pancreas. The expression of VMAT1 and VMAT2 was also examined in infants with hyperinsulinemic hypoglycemia and in adults with pancreatic endocrine tumors (PETs). Using immunohistochemistry (IHC) and in situ hybridization (ISH), we demonstrated the mutually exclusive expression of VMAT1 in endocrine cells of the duct system and of VMAT2 in many cells of the islets of Langerhans. By confocal laser scanning microscopy, VMAT1-positive cells were identified as enterochromaffin (EC) cells and VMAT2-positive cells as ß-cells. In PETs, VMAT1 was found exclusively in all serotonin-containing tumors. In contrast, VMAT2 expression was lost in many insulinomas, independent of their biological behavior. VMAT2 was expressed by some non-insulin-producing tumors. The mutually exclusive expression of VMAT1 in EC cells and of VMAT2 in ß-cells suggests that both cell types store monoamines. Monoamine storage mediated by VMAT1 in EC cells is apparently maintained in EC cell tumors. In contrast, many insulinomas appear to lose their ability to accumulate monoamines via VMAT2. (J Histochem Cytochem 51:10271040, 2003)
Key Words:
vesicular monoamine, transporter, EC cell, pancreatic islet, insulin, glucagon, somatostatin, pancreatic polypeptide, neuroendocrine tumor

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Goland, M. Freeby, R. Parsey, Y. Saisho, D. Kumar, N. Simpson, J. Hirsch, M. Prince, A. Maffei, J. J. Mann, et al.
11C-Dihydrotetrabenazine PET of the Pancreas in Subjects with Long-Standing Type 1 Diabetes and in Healthy Controls
J. Nucl. Med.,
March 1, 2009;
50(3):
382 - 389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Raffo, K. Hancock, T. Polito, Y. Xie, G. Andan, P. Witkowski, M. Hardy, P. Barba, C. Ferrara, A. Maffei, et al.
Role of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazine
J. Endocrinol.,
July 1, 2008;
198(1):
41 - 49.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-P. Kung, C. Hou, B. P. Lieberman, S. Oya, D. E. Ponde, E. Blankemeyer, D. Skovronsky, M. R. Kilbourn, and H. F. Kung
In Vivo Imaging of {beta}-Cell Mass in Rats Using 18F-FP-(+)-DTBZ: A Potential PET Ligand for Studying Diabetes Mellitus
J. Nucl. Med.,
July 1, 2008;
49(7):
1171 - 1176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Uccella, R. Cerutti, D. Vigetti, D. Furlan, R. Oldrini, I. Carnevali, G. Pelosi, S. La Rosa, A. Passi, and C. Capella
Histidine Decarboxylase, DOPA Decarboxylase, and Vesicular Monoamine Transporter 2 Expression in Neuroendocrine Tumors: Immunohistochemical Study and Gene Expression Analysis
J. Histochem. Cytochem.,
August 1, 2006;
54(8):
863 - 875.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Anlauf, M. K.-H. Schafer, T. Schwark, N. von Wurmb-Schwark, V. Brand, B. Sipos, H.-P. Horny, R. Parwaresch, W. Hartschuh, L. E. Eiden, et al.
Vesicular Monoamine Transporter 2 (VMAT2) Expression in Hematopoietic Cells and in Patients with Systemic Mastocytosis
J. Histochem. Cytochem.,
February 1, 2006;
54(2):
201 - 213.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Maffei, Z. Liu, P. Witkowski, F. Moschella, G. D. Pozzo, E. Liu, K. Herold, R. J. Winchester, M. A. Hardy, and P. E. Harris
Identification of Tissue-Restricted Transcripts in Human Islets
Endocrinology,
October 1, 2004;
145(10):
4513 - 4521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Anlauf, M. K.-H. Schafer, C. Depboylu, W. Hartschuh, L. E. Eiden, G. Kloppel, and E. Weihe
The Vesicular Monoamine Transporter 2 (VMAT2) Is Expressed by Normal and Tumor Cutaneous Mast Cells and Langerhans Cells of the Skin but Is Absent from Langerhans Cell Histiocytosis
J. Histochem. Cytochem.,
June 1, 2004;
52(6):
779 - 788.
[Abstract]
[Full Text]
[PDF]
|
 |
|
The Journal of Histochemistry & Cytochemistry
is owned, published, and licensed by
The Histochemical Society © 2003
|
|
|